Virios Therapeutics Llc Stock Today
| VIRI Stock | USD 0.16 0.01 5.88% |
Performance0 of 100
| Odds Of DistressOver 85
|
Virios Therapeutics is trading at 0.16 as of the 3rd of October 2024. This is a 5.88 percent decrease since the beginning of the trading day. The stock's open price was 0.17. Virios Therapeutics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Virios Therapeutics Llc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of April 2024 and ending today, the 3rd of October 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 17th of December 2020 | Category Healthcare | Classification Health Care |
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia. The company has 27.76 M outstanding shares of which 469.93 K shares are at this time shorted by private and institutional investors with about 0.64 trading days to cover. More on Virios Therapeutics Llc
Moving together with Virios Stock
| 0.65 | DYAI | Dyadic International | PairCorr |
| 0.64 | VTYX | Ventyx Biosciences | PairCorr |
| 0.64 | ERNA | Eterna Therapeutics | PairCorr |
| 0.81 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
Moving against Virios Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Virios Stock Highlights
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, SBF 120, SBF 120 Gross, CAC All-Tradable, NASDAQ Health Care, CAC All Tradable, CAC Mid 60, CAC Mid Small, CAC All Shares, CAC Energy Oil, CAC All-Tradable Net, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
Debt LevelsVirios Therapeutics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Virios Therapeutics' financial leverage. It provides some insight into what part of Virios Therapeutics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||
Virios Therapeutics Llc (VIRI) is traded on NASDAQ Exchange in USA. It is located in 44 Milton Avenue, Alpharetta, GA, United States, 30009 and employs 4 people. Virios Therapeutics is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.32 M. Virios Therapeutics Llc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 27.76 M outstanding shares of which 469.93 K shares are at this time shorted by private and institutional investors with about 0.64 trading days to cover.
Virios Therapeutics Llc currently holds about 7.7 M in cash with (4.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Virios Therapeutics Probability Of Bankruptcy
Ownership AllocationVirios Therapeutics Llc shows a total of 27.76 Million outstanding shares. Virios Therapeutics Llc has 6.74 % of its outstanding shares held by insiders and 3.6 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Virios Ownership Details
Virios Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Northwestern Mutual Wealth Management Co | 2024-06-30 | 19.1 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 15 K | |
| Cetera Advisors Llc | 2024-03-31 | 11.9 K | |
| Cetera Investment Advisers | 2024-06-30 | 11.9 K | |
| Virtu Financial Llc | 2024-06-30 | 11.8 K | |
| Wiley Bros.-aintree Capital, Llc | 2024-06-30 | 11 K | |
| William Howard & Co Financial Advisors Inc. | 2024-06-30 | 10.1 K | |
| One + One Wealth Management, Llc | 2024-06-30 | 10 K | |
| Tower Research Capital Llc | 2024-06-30 | 6.9 K | |
| Vanguard Group Inc | 2024-06-30 | 208.9 K | |
| Geode Capital Management, Llc | 2024-06-30 | 174.5 K |
Virios Therapeutics Historical Income Statement
Virios Stock Against Markets
Virios Therapeutics Corporate Management
| Gregory Duncan | Chairman CEO | Profile | |
| Carol Duffy | Chief Advisor | Profile | |
| Ralph MPH | Senior Operations | Profile | |
| Angela Walsh | SVP CFO | Profile |
Additional Information and Resources on Investing in Virios Stock
When determining whether Virios Therapeutics Llc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Virios Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Virios Therapeutics Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Virios Therapeutics Llc Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virios Therapeutics Llc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Virios Therapeutics. If investors know Virios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Virios Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Return On Assets (0.68) | Return On Equity (1.20) |
The market value of Virios Therapeutics Llc is measured differently than its book value, which is the value of Virios that is recorded on the company's balance sheet. Investors also form their own opinion of Virios Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Virios Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virios Therapeutics' market value can be influenced by many factors that don't directly affect Virios Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virios Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Virios Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virios Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.